Alternative performance measures, Report ‘Coviditis’ and EBITDAC

Audit & Assurance, Financial Reporting

This is a two-part podcast series.

Firstly, it is important to note that the use of terms such as EBITDAC and Coviditis are in no way to detract from the seriousness of the effect of the pandemic on people, families, communities, businesses and economies but is intended to draw out the detrimental impact that Covid-19 could have on effective financial reporting.

This two-part series is intended to help preparers improve their financial reporting for the forthcoming reporting season, whether in interim reports or annual reports.

PART ONE

In part one we discuss the general use of alternative performance measures in financial statements and how regulators have sought to battle against their misuse in management reports, interim reports, annual reports, and prospectuses.

PART TWO

In part two we build on that overview of the general use of alternative performance measures by considering their use in the light of the Covid-19 pandemic and consequential lock down.

Find out more

To discuss the topics raised in this webinar or to find out more about how we can help your organisation, please contact our Head of Financial Reporting Advisory and Company Law, Neil Parsons on neil.parsons@mhllp.co.uk or complete our online enquiry form and a member of the team will be in contact.